Nachrichten zur Gilead Sciences Inc. Aktie

Gilead (GILD) Kite Reports Positive Data on CAR T-Cell Therapy

Gilead (GILD) reports positive long-term results from the phase I/II study on Tecartus (brexucabtagene autoleucel) for acute lymphoblastic leukemia....…

Medizinische Innovationen brauchen eine gesunde Industriepolitik / Auftaktveranstaltung Fortschrittsdialog am 7. Februar mit über 150 Gästen in Berlin

Fortschrittsdialog: Berlin (ots) - Mit der Veranstaltungsreihe "Gesunde Industriepolitik - Fortschrittsdialog" möchten sieben - in Deutschland fest verwurzelte - forschende…

Gilead Sciences: 4 Questions With See Phan: Discovering New Therapies in Breast Cancer

NORTHAMPTON, MA / ACCESSWIRE / February 8, 2023 / As a practicing physician and cancer researcher for more than 20…

Gilead Sciences: Neues Kursziel

Milwaukee (www.aktiencheck.de) - Rating-Update: Brian Skorney, Analyst von Robert W. Baird, stuft die Aktie von Gilead Sciences Inc. (ISIN: US3755581036, WKN:…

Form 8-K GILEAD SCIENCES, INC. For: Feb 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Gilead Sciences a Good Stock to Buy Now?

Gilead Sciences breast cancer drug, Trodelvy, just took a big step forward....…

Gilead Sciences: FDA Approves Trodelvy In Pre-treated HR+/HER2- Metastatic Breast Cancer

FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) said that the U.S. Food and Drug Administration approved Trodelvy (sacituzumab govitecan-hziy)…

Ford, Starbucks fall; Clorox, Gilead Sciences rise

Stocks that traded heavily or had substantial price changes Friday: Ford, Starbucks fall; Clorox, Gilead Sciences rise...…

Gilead (GILD) Q4 Earnings & Sales Top on Biktarvy & Oncology

Gileads (GILD) Q4 earnings and sales beat on strong HIV and oncology business. The guidance for 2023 was also ahead…

Biotech Report: Qiagen (QIA) fest, Evotec (EVT) und MorphoSys (MOR) konsolidieren

Biotech-Aktien zeigten sich im deutschen Handel uneinheitlich. Während Qiagen und BB Biotech zulegen konnten, verlieren Evotec und MorphoSys. …

Gilead wins FDA nod for Trodelvy in new breast cancer indication

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Gilead Sciences Stock a Screaming Buy After Its Strongest Results in 7 Years?

Gileads strongest growth since 2015 comes with an asterisk....…

Gilead Sciences (GILD) Q4 2022 Earnings Call Transcript

GILD earnings call for the period ending December 31, 2022....…

Why Gilead Sciences Stock Is Trading Higher After Hours

Gilead Sciences Inc (NASDAQ: GILD) shares are trading higher in Thursday's after-hours session after the company reported read more...…

UPDATE 1-Gilead profit beats Street expectations on COVID and HIV sales

... Erman and Sriparna Roy Feb 2 (Reuters) - Gilead Sciences Inc......…

Gilead Sciences Inc. Q4 Profit Increases, beats estimates

FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) reported earnings for its fourth quarter that increased from the same period…

Gilead stock jumps 5% after Q4 beat, dividend increase

Shares of Gilead Sciences Inc. GILD rose more than 5% in the extended session Thursday after the pharma company reported…

Gilead Sciences 4Q Profit Surges on Oncology, HIV Sales

Gilead Sciences 4Q Profit Surges on Oncology, HIV Sales...…

Gilead profit beats Street expectations on COVID and HIV sales

...By Michael Erman and Sriparna Roy (Reuters) - Gilead Sciences......…

Gilead Sciences: Toward Health Equity for Black People Impacted by TNBC

NORTHAMPTON, MA / ACCESSWIRE / February 2, 2023 / Gilead SciencesOriginally Published by Gilead SciencesRacism and the impact of social…

Why Gilead (GILD) Might Surprise This Earnings Season

Gilead (GILD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…

Why Gilead (GILD) is Poised to Beat Earnings Estimates Again

Gilead (GILD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Gilead, Arcellx close agreement on developing T-cell therapy for multiple myeloma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Presseeinladung Auftakt Veranstaltungsreihe Gesunde Industriepolitik Fortschrittsdialog

Fortschrittsdialog: Berlin (ots) - Die Pharmaunternehmen Amgen, Bayer, Boehringer Ingelheim, Gilead, GlaxoSmithKlein (GSK), Novartis, Roche und die IGBCE starten mit…

Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know

Gilead Sciences (GILD) closed the most recent trading day at $83.62, moving -0.54% from the previous trading session....…

Gilead Sciences (GILD) Earnings Expected to Grow: Should You Buy?

Gilead (GILD) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Gilead (GILD) Gains 21% in a Year: Will the Trend Continue?

Biotech giant Gilead (GILD) gains 21% in the past 12 months as its core HIV business maintains momentum despite volatility....…

Gilead Sciences: Kursziel angehoben

Minneapolis (www.aktiencheck.de) - Rating-Update: Do Kim, Analyst von Piper Sandler, bestätigt das Rating "overweight" für die Aktie von Gilead Sciences…

Strata Oncology Announces Addition of Gilead as Strata PATH Trial Collaborator

Gilead to supply TRODELVY for prospective, pan-tumor trial ANN ARBOR, Mich., Jan. 18, 2023 /PRNewswire/ -- Strata Oncology, Inc. a…

ROUNDUP: EU sichert sich bis zu 2,25 Millionen Flaschen Remdesivir gegen Covid

BRÜSSEL (dpa-AFX) - Die Europäische Union hat sich weitere bis zu 2,25 Millionen Fläschchen des Corona-Medikaments…

EU sichert sich bis zu 2,25 Millionen Flaschen Remdesivir gegen Covid

BRÜSSEL (dpa-AFX) - Die Europäische Union hat sich weitere bis zu 2,25 Millionen Fläschchen des Corona-Medikaments…

dpa-AFX ProFeed